$赛诺菲-安万特(SNY)$
amcenestrant,HR+HER2-L1mBC适应症,Expected submission in 2024【AMEERA-5 III期】;不过II期 L2/L3mBC 失败;
LILLY, Imlunestrant,L2/L3mBC,中期分析延后至Jun 2023【EMBER-3】;
RHHBY,Giredestrant,L2/L3mBC,II 期acelERA失败;